Navigation Links
Bionomics Achieves US$1 Million Milestone Payment from Genmab
Date:2/19/2008

s for cancer to the clinic."

The CEO of Genmab Lisa N Drakeman, PhD commented: "We are pleased to reach the next level of development with these targets and look forward to continuing the collaboration with Bionomics."

Professor Jan G J van de Winkel, PhD, Chief Scientific Officer of Genmab added: "This milestone has been reached following extensive studies by Genmab on the Bionomics targets. The work we have undertaken has confirmed and extended the work performed by Bionomics, further supporting their potential as new targets for therapeutic antibodies."

Bionomics has the rights and is actively developing a large number of additional proprietary proteins discovered through its angiogenesis program, including BNO69. In addition Bionomics' anti-cancer drug BNC105 will soon commence a Phase 1 clinical trial at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Western Hospital cancer centres in Melbourne for the treatment of solid tumours including breast, colon and prostate cancers. BNC105 was identified using the Angene(R) platform. Bionomics' Investigational New Drug (IND) submission for BNC105 was accepted by the US Food and Drug Administration in November 2007.

About Bionomics Limited:

Bionomics (ASX: BNO) discovers and develops innovative therapeutics for cancer and diseases of the central nervous system. Bionomics has small molecule product development programs in the areas of cancer, anxiety, epilepsy and multiple sclerosis. Bionomics' discovery and development activities are driven by its three technology platforms: Angene(R), the company's angiogenesis target and drug discovery platform, incorporates a variety of genomics tools to identify and validate novel angiogenesis targets. MultiCore(R) is Bionomics' proprietary, diversity orientated chemistry platform for the discovery of small molecule drugs. ionX(R) is a set of novel technologies for the identification of drugs targeting ion channels for diseases of t
'/>"/>

SOURCE Bionomics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
2. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
3. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
4. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
7. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
8. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
9. BioVascular Inc. Closes $10.87 Million Series C Financing
10. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
11. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  Restore Health, a leading personalized ... announced that it is now offering pharmacogenetics testing ... individual based upon their particular genetic makeup. Comprehensive ... interaction between a patient,s genetics and their entire ... to provide this new service to healthcare providers ...
(Date:7/24/2014)... 24, 2014  Mettler-Toledo International Inc. (NYSE: ... Provided below are the highlights: , Sales ... compared with the prior year. Reported sales increased 5% ... Net earnings per diluted share as reported (EPS) were ... 2013. Adjusted EPS was $2.57, an increase of 9% ...
(Date:7/24/2014)... 2014  IGI Laboratories, Inc. (NYSE MKT: IG), a New ... its financial results for the second quarter ended June 30, ... Total revenues of $6.5 million in the second quarter of ... 2013 , Total revenues of $13.3 million for the ... over the same period in 2013 , Total revenues ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
(Date:7/25/2014)... According to the new report "Sapphire Technology ... Geography - Analysis & Forecast to 2013 - 2020", ... reach $3.01 Billion by 2020 at a CAGR of ... is expected to reach $6.17 billion by 2020 at ... of application and geography. , Browse more than 65 ...
(Date:7/25/2014)... 2014 Training Mask LLC, is proud ... an endorsement agreement to promote the mask and its’ ... for over 10 years, and ran over 30 ultra ... of the Angeles Crest 100-mile endurance run. Brian is ... of the endurance, strength and conditioning paradigm. He created ...
(Date:7/25/2014)... attack patients could be treated more quickly after ... electrocardiogram (ECG) and blood test on arrival, is ... pain, a new study shows., The findings of ... Emergency Medicine Journal, could potentially make a huge ... pain is the most common reason for emergency ...
(Date:7/25/2014)... 25, 2014 DON’T PAUSE is a popular ... bloating, hot flashes, mood swings, burning tongue menopause ... Shoreh Ershadi. The AntiAging Institute of California is now offering ... women to try this revolutionary product. For a limited time, ... a third bottle at no charge. , Water ...
(Date:7/25/2014)... and desires in initial romantic encounters determine the fate ... those initial "sparks" necessary to fuel sexual desire and ... a desirable trait for both men and women on ... the other person? Do men perceive responsive women as ... women,s perceptions of men? A study published in ...
Breaking Medicine News(10 mins):Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 6Health News:Training Mask LLC Announces the Signing of World-Renowned Coach Brian MacKenzie 2Health News:Training Mask LLC Announces the Signing of World-Renowned Coach Brian MacKenzie 3Health News:Heart attack patients could be treated more quickly after Manchester research 2Health News:AntiAging Institute of California Now Offers DON'T PAUSE for Menopause with a Special Promotion 2Health News:Why do men prefer nice women? 2Health News:Why do men prefer nice women? 3
... health-care workers getting vaccine , TUESDAY, Nov. 3 (HealthDay News) ... doses available and is on track to have another 10 ... Tuesday. , So far, that isn,t enough to prevent long ... officials had projected earlier this week. , "We,re having a ...
... ... (EHR) , ... Scottsdale, AZ (PRWEB) November 3, 2009 -- MxSecure, Inc. , the ... multi-specialty clinics and community health centers, today announced an agreement with HealthCare ...
... ... online selection of plastic card printing to offer PVC materials in addition to traditional ... ... plastic card printing innovations by adding new PVC material options to their plastic card ...
... Nov. 3 , What: ... LoJack Corporation (Nasdaq: LOJN ) has hosted an ... valuable information related to Alzheimer,s including: , The ... day-to-day challenges faced by people with Alzheimer,s and their ...
... 3 WebMD Health Corp. (Nasdaq: WBMD ), ... results for the three months ended September 30, 2009. ... financial and operating performance," said Wayne Gattinella, President and ... environment, WebMD continues to expand its audience, revenue and ...
... the largest nurses, union and professional association in U.S. history ... of the affiliation agreement vote by delegates representing 80 percent ... Even as a number of state affiliates inexplicably failed to ... moved forward to create the 150,000 member RN "Super Union." ...
Cached Medicine News:Health News:CDC Urges Patience As More Swine Flu Shots Arrive 2Health News:Medical Transcription Service Provider, MxSecure, Teams with HealthCare Partners/PACIS to Accelerate Physician EHR Adoption 2Health News:Medical Transcription Service Provider, MxSecure, Teams with HealthCare Partners/PACIS to Accelerate Physician EHR Adoption 3Health News:My1Stop.com Expands Plastic Card Offering to Include PVC Material Choices 2Health News:November is National Alzheimer's Awareness Month 2Health News:WebMD Announces Third Quarter Financial Results 2Health News:WebMD Announces Third Quarter Financial Results 3Health News:WebMD Announces Third Quarter Financial Results 4Health News:WebMD Announces Third Quarter Financial Results 5Health News:WebMD Announces Third Quarter Financial Results 6Health News:WebMD Announces Third Quarter Financial Results 7Health News:WebMD Announces Third Quarter Financial Results 8Health News:WebMD Announces Third Quarter Financial Results 9Health News:WebMD Announces Third Quarter Financial Results 10Health News:WebMD Announces Third Quarter Financial Results 11Health News:WebMD Announces Third Quarter Financial Results 12Health News:WebMD Announces Third Quarter Financial Results 13Health News:WebMD Announces Third Quarter Financial Results 14Health News:WebMD Announces Third Quarter Financial Results 15Health News:WebMD Announces Third Quarter Financial Results 16Health News:WebMD Announces Third Quarter Financial Results 17Health News:WebMD Announces Third Quarter Financial Results 18Health News:WebMD Announces Third Quarter Financial Results 19Health News:WebMD Announces Third Quarter Financial Results 20Health News:WebMD Announces Third Quarter Financial Results 21Health News:WebMD Announces Third Quarter Financial Results 22Health News:WebMD Announces Third Quarter Financial Results 23Health News:United American Nurses Vote Brings 'Super Union' and New Chapter for RN Power Closer to Achievement 2Health News:United American Nurses Vote Brings 'Super Union' and New Chapter for RN Power Closer to Achievement 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: